|
| 37738153 | Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions. | Clin Infect Dis | 2024 |
| 37740559 | Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. | Clin Infect Dis | 2024 |
| 36262037 | Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics. | Clin Infect Dis | 2023 |
| 37962552 | Interlaboratory comparison of <i>Pseudomonas aeruginosa</i> phage susceptibility testing. | J Clin Microbiol | 2023 |
| 37843121 | The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions. | Clin Infect Dis | 2023 |
| 37843122 | The Future Ain't What It Used to Be⿦Out With the Old⿦In With the Better: Antibacterial Resistance Leadership Group Innovations. | Clin Infect Dis | 2023 |
| 37843120 | Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group. | Clin Infect Dis | 2023 |
| 37843118 | Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group. | Clin Infect Dis | 2023 |
| 37698412 | Daily fosfomycin versus levofloxacin for complicated urinary tract infections. | mBio | 2023 |
| 37580166 | Desirability of Outcome Ranking for Status Epilepticus: A Benefit-Risk Approach to Design and Analyses of Clinical SE Trials. | Neurology | 2023 |
| 37637218 | Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial. | BMJ Neurol Open | 2023 |
| 37154071 | International Epidemiology of Carbapenemase-Producing Escherichia coli. | Clin Infect Dis | 2023 |
| 37073571 | Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs. | Clin Infect Dis | 2023 |
| 37230248 | Which trial do we need? Optimal antibiotic duration for patients with sepsis. | Clin Microbiol Infect | 2023 |
| 36774938 | Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. | Lancet Microbe | 2023 |
| 36031403 | Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. | Clin Infect Dis | 2023 |
| 34767753 | Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. | Lancet Infect Dis | 2022 |
| 35615299 | A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection. | Open Forum Infect Dis | 2022 |
| 35578360 | Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial. | Trials | 2022 |
| 35437261 | Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack. | Neurology | 2022 |
| 36578069 | Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial. | Trials | 2022 |
| 36381622 | Clinical Impact of Ceftriaxone Resistance in <i>Escherichia coli</i> Bloodstream Infections: A Multicenter Prospective Cohort Study. | Open Forum Infect Dis | 2022 |
| 35040920 | Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial. | JAMA Pediatr | 2022 |
| 34490854 | Pragmatic trials of pain therapies: a systematic review of methods. | Pain | 2022 |
| 34510135 | Benefit-risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations. | Pain | 2022 |
| 33146706 | Using a Composite Maternal-Infant Outcome Measure in Tuberculosis-Prevention Studies Among Pregnant Women. | Clin Infect Dis | 2021 |
| 33588438 | Antibacterial Resistance Leadership Group 2.0: Back to Business. | Clin Infect Dis | 2021 |
| 33772269 | Day at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis. | Clin Infect Dis | 2021 |
| 34477459 | Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. | Stroke | 2021 |
| 34244703 | Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial. | JAMA Neurol | 2021 |
| 33978146 | Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health Administration. | Clin Infect Dis | 2021 |
| 33309946 | On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes. | Contemp Clin Trials | 2021 |
| 33245333 | Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance. | Clin Infect Dis | 2021 |
| 33449513 | Composite outcomes for pain clinical trials: considerations for design and interpretation. | Pain | 2021 |
| 33393014 | Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative. | Ther Innov Regul Sci | 2021 |
| 30980317 | Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes. | Lifetime Data Anal | 2020 |
| 33521483 | Essential statistical principles of clinical trials of pain treatments. | Pain Rep | 2020 |
| 31843583 | Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations. | J Pain | 2020 |
| 31858640 | Analysis of ordered composite endpoints. | Stat Med | 2020 |
| 31739312 | Presenting Risks and Benefits: Helping the Data Monitoring Committee Do Its Job. | Ann Intern Med | 2020 |
| 31738398 | Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections. | Clin Infect Dis | 2020 |
| 31734695 | Simultaneous Evaluation of Diagnostic Assays for Pharyngeal and Rectal Neisseria gonorrhoeae and Chlamydia trachomatis Using a Master Protocol. | Clin Infect Dis | 2020 |
| 33159526 | Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial. | JAMA Neurol | 2020 |
| 33042476 | Interim Monitoring for Futility in Clinical Trials with Two Co-primary Endpoints Using Prediction. | Stat Biopharm Res | 2020 |
| 32668111 | Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. | N Engl J Med | 2020 |
| 32666831 | Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial. | Clin Trials | 2020 |
| 32247863 | Analytical Evaluation of the Abbott RealTime CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Swabs. | J Mol Diagn | 2020 |
| 32151332 | Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. | Lancet Infect Dis | 2020 |
| 32356696 | Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM. | Ann Am Thorac Soc | 2020 |
| 32520773 | Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. | Pain | 2020 |